Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT07742241

Efficacy Study of a Repairing Cream in Atopic Dermatitis

Conditions: Atopic Dermatitis (AD)

Sex: All
Ages: 2 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 116
Sponsor: Instituto de Investigacion Biotecnologica, Farmaceutica y Medicamentos Huerfanos, S.L.

Location: Hospital Universitario Virgen de las Nieves Granada

Summary

The application of DermControl®, a repair cream based on hyaluronic acid, sh-oligopeptide-1 and polyphenols, in combination with topical corticosteroids, could help to improve epidermal barrier function in patients with atopic dermatitis, improving their symptoms and Quality of Life.

Eligibility Criteria

Inclusion Criteria: * Patients from 2 years of age diagnosed with AD by a dermatologist according to Hanifin and Rajka criteria, with a disease duration of at least six months. Exclusion Criteria: * Presence of any clinical infection in the area designated for measurement. * History of cancer or immunosuppression. * Coexisting inflammatory skin conditions such as psoriasis or hidradenitis suppurativa.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07742241). StuddyBuddy aggregates publicly available trial information.